New Head of Trump’s Cancer Panel Speculated About Links Between Vaccines and Cancer

Share via:


An epidemiologist who has speculated about whether there is a connection between Covid-19 vaccines and “turbo cancer” in young people, and works as chief epidemiologist at a company that sells ivermectin alongside reviews that claim it has efficacy as a cancer treatment, has been appointed by president Donald Trump to a key position overseeing the National Cancer Program.

Harvey Risch, a professor emeritus of epidemiology at the Yale School of Public Health, announced his appointment as chair of the…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

New Head of Trump’s Cancer Panel Speculated About Links Between Vaccines and Cancer


An epidemiologist who has speculated about whether there is a connection between Covid-19 vaccines and “turbo cancer” in young people, and works as chief epidemiologist at a company that sells ivermectin alongside reviews that claim it has efficacy as a cancer treatment, has been appointed by president Donald Trump to a key position overseeing the National Cancer Program.

Harvey Risch, a professor emeritus of epidemiology at the Yale School of Public Health, announced his appointment as chair of the…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

9to5Mac Top Stories: iOS 26.3 beta, App Store changes,...

Welcome to 9to5Mac’s top stories of the week,...

Meesho Emerges Biggest Winner In A Mixed Week For...

SUMMARY Shares of 26 of the 50 new-age tech...

Best Nintendo Switch 2 Controllers (2025), Tested and Reviewed

The launch of Switch 2 brings with it a...

Popular